Debut Plus

965.85

+5.28 +0.55%

As of 09 Sept 2026 · delayed

NSE Listed

LT-ASM · ASM 1 · ST-ASM · ASM 1
What does LT-ASM · ASM 1 · ST-ASM · ASM 1 mean?
BSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-08-25
NSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-08-26
BSE · Short Term Additional Surveillance Measure (ASM 1)ST-ASM catches short bursts: a beta-adjusted close-to-close move beyond ±25% in 5 trading days (or ±40% in 15) combined with concentrated trading — or a 75%+ monthly range with fewer than 100–200 unique traders. Practical meaning: margins jump to 50–100% for a few weeks to cool a spike; it either lapses quickly or escalates into LT-ASM if the move sustains.Criteria: Short-term (5 / 15 / 30-day) price-volume abnormality — high-low and close-to-close price variation over the window. Adds 100% margin and a 5% (then 2%) price band.Exchange notice · 2026-08-12

Shilpa Medicare Ltd. (SHILPAMED)

Volume: 6,94,978Avg Vol 1W: 10,03,205.2Avg Vol 1M: 12,90,316.8552W Range:259.5980.1
Key Ratios
Checked 5h ago
Market Cap₹18,788 Cr
Current Price₹965.85
Previous Close₹960.57
High / Low (52w)₹980.1 / ₹259.5
Volume6,94,978
Avg Vol (1W)10,03,205.2
Avg Vol (1M)12,90,316.85
Stock P/E66.07
Book Value₹132.49
Dividend Yield6%
ROE9.39%
ROA8.02%
Revenue (TTM)₹1,549 Cr
Revenue Growth11.7%
Profit Margin17.67%
Total Debt₹232 Cr
Shares Outstanding20 Cr
Face Value₹1
EPS (TTM)₹14.54
P/B7.26
Debt / Equity0.25
50 DMA₹742.27
200 DMA₹480.76
Day change+0.55%
SurveillanceLT-ASM · ASM 1 · ST-ASM · ASM 1
Price Chart
965.85 131.40% · 1Y
9662672.1Cr
2025-09-10
2026-09-09

20-day avg volume: 12.9L shares

Pros
  • Pays a dividend yield of 6.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 19% YoY.
  • Stock trades at a high P/E of 66.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹344 Cr₹319 Cr₹331 Cr₹321 Cr₹370 Cr₹410 Cr₹437 Cr₹466 Cr
EBITDA₹63 Cr₹53 Cr₹58 Cr₹69 Cr₹80 Cr₹85 Cr₹91 Cr₹104 Cr
Net Profit₹18 Cr₹32 Cr₹15 Cr₹47 Cr₹44 Cr₹45 Cr₹108 Cr₹101 Cr
EPS
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹1,310 Cr₹126 Cr₹92 Cr₹135 Cr₹166 Cr₹201 Cr₹1,549 Cr₹189 Cr
EBITDA₹230 Cr₹36 Cr₹22 Cr₹43 Cr₹29 Cr₹52 Cr₹325 Cr₹50 Cr
Net Profit₹78 Cr₹-6 Cr₹21 Cr₹31 Cr₹16 Cr₹71 Cr₹243 Cr₹65 Cr
EPS4.0212.44
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹1,610 Cr₹1,989 Cr₹2,632 Cr₹2,875 Cr₹2,904 Cr₹3,093 Cr₹3,311 Cr₹3,706 Cr
Total Liabilities₹420 Cr₹668 Cr₹1,165 Cr₹1,064 Cr₹1,130 Cr₹1,293 Cr₹947 Cr₹1,114 Cr
Equity₹1,190 Cr₹1,321 Cr₹1,467 Cr₹1,811 Cr₹1,774 Cr₹1,800 Cr₹2,364 Cr₹2,591 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹183 Cr₹167 Cr₹95 Cr₹140 Cr₹212 Cr₹178 Cr₹179 Cr₹403 Cr
Investing₹-196 Cr₹-290 Cr₹-404 Cr₹-285 Cr₹-233 Cr₹-167 Cr₹-199 Cr₹-326 Cr
Financing₹10 Cr₹176 Cr₹436 Cr₹83 Cr₹46 Cr₹47 Cr₹63 Cr₹14 Cr
Free Cash Flow₹183 Cr₹167 Cr₹95 Cr₹140 Cr₹212 Cr₹178 Cr₹179 Cr₹403 Cr
Shareholding
Promoter 40.13% Institutions 19.44% Public 40.43%
Efficiency & Working Capital
ROCE10.7%
Interest Coverage6
Dividend Payout
Debtor Days123 d
Inventory Days87 d
Payable Days34 d
Cash Conversion Cycle176 d
Working Capital Days210 d
Shareholding Details

As of 2026-06-30

Promoter40.1%
FII11.4%
DII8.1%
Institutions19.4%
Public40.4%
Promoter Pledge8.7%
No. of Shareholders60,926
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Apr 2024Apr 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters50%44.4%44.4%44.4%44.3%44.2%44.2%44.2%44.2%40.1%40.1%40.1%
FIIs5.7%9.7%9.7%9.1%9.6%9.9%11%11.2%10.9%11%11.1%11.4%
DIIs1.6%7.5%6.1%7.6%8.2%8.3%7.5%7.5%7.7%8.3%8.6%8.1%
Public42.7%38.4%39.8%38.9%37.9%37.6%37.3%37.1%37.2%40.6%40.2%40.4%
Promoter Pledge90.4%90.4%90.4%90.4%7.9%7.9%7.9%7.9%7.9%8.7%8.7%8.7%
No. of Shareholders44,79344,80944,80941,07242,78449,03450,10848,63652,06553,79953,41060,926
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Vishnukant Chaturbhuj BhutadaShareholding of Promoter and Promoter Group6.5%1.27 Cr
Dharmavati BhutadaShareholding of Promoter and Promoter Group6.4%1.24 Cr
Ravi Kumar InnaniShareholding of Promoter and Promoter Group4.1%80,12,740
Suraj Kumar InaniPublic Shareholding4%78,41,390
Om Prakash InaniShareholding of Promoter and Promoter Group2.9%57,35,382
Deepak Kumar InnaniShareholding of Promoter and Promoter Group2.8%54,67,920
Kantadevi InaniShareholding of Promoter and Promoter Group2.6%50,80,192
Sbi Life Insurance Co. LtdPublic Shareholding2.3%45,27,562
Sunidhi Capital Private LimitedPublic Shareholding2.3%44,00,000
Cohesion Mk Best Ideas Sub-trustPublic Shareholding2.2%42,52,274
Keshav BhutadaShareholding of Promoter and Promoter Group2.1%40,00,000
Madhav Vishnukant BhutadaShareholding of Promoter and Promoter Group2.1%40,00,000
Amal ParikhPublic Shareholding1.7%33,81,156
Dovetail India Fund Class 5 SharesPublic Shareholding1.7%33,37,132
Ramakant InnaniShareholding of Promoter and Promoter Group1.5%29,95,556
Vishnukanth C Bhutada .Shareholding of Promoter and Promoter Group1.4%26,72,260
Taradevi InnaniShareholding of Promoter and Promoter Group1.3%24,99,996
Vishnukanta InaniShareholding of Promoter and Promoter Group1.2%24,24,996
Bandhan Healthcare FundPublic Shareholding1.2%24,31,840
Brijgopal InnaniShareholding of Promoter and Promoter Group1.2%23,49,732
Elm Park Fund LimitedPublic Shareholding1.2%23,00,000
Icici Prudential Elss Tax Saver FundPublic Shareholding1.2%22,90,936
Natamal InnaniShareholding of Promoter and Promoter Group1.2%22,62,464
Shakuntalabai InnaniShareholding of Promoter and Promoter Group1.2%22,58,372
Sapphire Intrex LimitedPublic Shareholding1.1%20,77,132
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Brijgopal Innani4,00,00017%2026-06-30
Om Prakash Inani4,00,0007%2026-06-30
Ramakant Innani13,50,00045.1%2026-06-30
Deepak Kumar Innani13,50,00024.7%2026-06-30
Vishnukant Chaturbhuj Bhutada20,00,00015.7%2026-06-30
Dharmavati Bhutada13,50,00010.9%2026-06-30
Board of Directors
NameDesignationYear
Omprakash InaniChairman & Non Executive Dir.2025
Vishnukant BhutadaED / MD / Promoter2025
Hetal GandhiIndependent Non Exe. Director2025
Sharath Reddy KalakotaE D & Wholetime Director2025
Kamal K SharmaIndependent Non Exe. Director2025
Anita BandyopadhyayIndependent Non Exe. Director2025
Ashraf Loutfy Abdelhamid AllamIndependent Non Exe. Director2025
Keshav BhutadaExecutive Director & CEO2025
Ritu TiwaryCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical product and services₹824 Cr99.3%
Power₹5 Cr0.6%
Others₹1 Cr0.1%
Segments — Geography
RegionRevenueShare
Within India₹319 Cr38.4%
Europe₹288 Cr34.7%
USA₹133 Cr16%
ROW₹91 Cr10.9%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1562020
Corporate Actions
TypeDateValueRemark
forthcoming2026-09-04Dividend (0.6/- per share)Final
dividend2026-09-04₹0.6 (60%)Final
forthcoming2026-09-04Dividend
forthcoming2026-08-05Board Meetings
bonus2025-10-031:11:1 Bonus Issue of Equity Shares
dividend2025-09-17₹1 (100%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20262,41029-0-012,439
20261,65429-1-001,682
2026300003
Insider / Designated-Person Trades

30 recent disclosure(s)

PRIYA INANIDisposal · 1,00,000
VISHNUKANT CHATURBHUJ BHUTADAPledge · 10,00,000
OMPRAKASH INANIPledge · 2,00,000
DEEPAK KUMAR INNANIPledge · 6,75,000
DHARMAVATI BHUTADAPledge · 6,75,000
BRIJGOPAL INNANIPledge · 2,00,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Qualified Institutional Placement (qip)13/04/2024 · 1,09,89,010
Company Information
Incorporated1987
ChairmanOmprakash Inani
AuditorB N P S and Associates LLP
Investor Email[email protected]
🌐 www.vbshilpa.com

📍 #12-6-214/A1, Hyderabad Road, Raichur, Karnataka, 584135

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search